Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

63 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phosphodiesterase 5 inhibitors: current status and potential applications.
Rotella DP. Rotella DP. Nat Rev Drug Discov. 2002 Sep;1(9):674-82. doi: 10.1038/nrd893. Nat Rev Drug Discov. 2002. PMID: 12209148 Review.
Optimization of substituted N-3-benzylimidazoquinazolinone sulfonamides as potent and selective PDE5 inhibitors.
Rotella DP, Sun Z, Zhu Y, Krupinski J, Pongrac R, Seliger L, Normandin D, Macor JE. Rotella DP, et al. J Med Chem. 2000 Dec 28;43(26):5037-43. doi: 10.1021/jm000336j. J Med Chem. 2000. PMID: 11150175
N-3-substituted imidazoquinazolinones: potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction.
Rotella DP, Sun Z, Zhu Y, Krupinski J, Pongrac R, Seliger L, Normandin D, Macor JE. Rotella DP, et al. J Med Chem. 2000 Apr 6;43(7):1257-63. doi: 10.1021/jm000081+. J Med Chem. 2000. PMID: 10753463
An update on COX-2 and farnesyltransferase inhibitor development.
Rotella DP. Rotella DP. Curr Opin Drug Discov Devel. 1998 Sep;1(2):165-74. Curr Opin Drug Discov Devel. 1998. PMID: 19649816 No abstract available.
221st ACS. Division of Medicinal Chemistry - inhibitors of HIV entry: potential new therapies for treatment of HIV infection.
Rotella D. Rotella D. IDrugs. 2001 Jun;4(6):629-30. IDrugs. 2001. PMID: 16001300 No abstract available.
Tadalafil Lilly ICOS.
Rotella DP. Rotella DP. Curr Opin Investig Drugs. 2003 Jan;4(1):60-5. Curr Opin Investig Drugs. 2003. PMID: 12625031 Review.
Osteoporosis: challenges and new opportunities for therapy.
Rotella DP. Rotella DP. Curr Opin Drug Discov Devel. 2002 Jul;5(4):477-86. Curr Opin Drug Discov Devel. 2002. PMID: 12197306 Review.
Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors.
Simpkins LM, Bolton S, Pi Z, Sutton JC, Kwon C, Zhao G, Magnin DR, Augeri DJ, Gungor T, Rotella DP, Sun Z, Liu Y, Slusarchyk WS, Marcinkeviciene J, Robertson JG, Wang A, Robl JA, Atwal KS, Zahler RL, Parker RA, Kirby MS, Hamann LG. Simpkins LM, et al. Among authors: rotella dp. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6476-80. doi: 10.1016/j.bmcl.2007.09.090. Epub 2007 Oct 1. Bioorg Med Chem Lett. 2007. PMID: 17937986
American Chemical Society--222nd national meeting. NPY antagonists and non-taxoid antitubule inhibitors.
Rotella D. Rotella D. IDrugs. 2001 Oct;4(10):1112-3. IDrugs. 2001. PMID: 15957071 No abstract available.
Discovery and structure-activity relationships of 2-benzylpyrrolidine-substituted aryloxypropanols as calcium-sensing receptor antagonists.
Yang W, Wang Y, Roberge JY, Ma Z, Liu Y, Michael Lawrence R, Rotella DP, Seethala R, Feyen JH, Dickson JK Jr. Yang W, et al. Among authors: rotella dp. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1225-8. doi: 10.1016/j.bmcl.2004.11.071. Bioorg Med Chem Lett. 2005. PMID: 15686947
63 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback